Results 71 to 80 of about 24,096 (164)

YAP/TAZ dull the STING of aging

The Journal of Cardiovascular Aging, 2022
Francisco, Jamie, Del Re, Dominic P.
openaire   +2 more sources

The Hippo signaling pathway in pediatric brain tumors: molecular mechanisms and therapeutic opportunities. [PDF]

Cancer Metastasis Rev
Papanikolaou MA, Gargalionis AN, Adamopoulos C, Piperi C.   +3 more
europepmc   +1 more source

Hippo signalling as a nexus in host-virus interactions. [PDF]

PLoS Pathog
Bahrami A, Walter C, Ardestani A.
europepmc   +1 more source

Taz

netbib, 2003
openaire   +2 more sources

DPP-Mediated Interaction of TAZ/β-Catenin Promotes the Differentiation of DPSCs into Odontoblasts. [PDF]

Int J Mol Sci
Chen Y, Petho A, Ganapathy A, Bakthavachalam V, Villani C, George A.   +5 more
europepmc   +1 more source

taz

netbib, 2002
openaire   +2 more sources

Inflammatory monocytes constrain YAP-induced cell proliferation. [PDF]

Sci Adv
Singh S, Tahmasian N, Liu JJ, Wang W, Haas L, Zhu Y, Griswold MM, Brodsky NN, Liu S, Kalish BT, Yimlamai D.   +10 more
europepmc   +1 more source

Correction: EZH2 blockade reverses doxorubicin resistance by inducing metabolic vulnerability and enhancing DNA damage in breast cancer. [PDF]

Front Pharmacol
Wang X, Ding Y, Mai Y, Li R, Shao X, Chen W, Li Y, Liu L, Wang H, Liu K, Niu Y, Li J, Xu G, Zhao Y.   +13 more
europepmc   +1 more source

The Ion channel, CFTR, assembles with HIPPO pathway proteins TAZ and YAP in polycystic kidney disease. [PDF]

J Biol Chem
Sharma A, Afshani M, Ciobanu C, Sharma T, Kress JT, Guggino WB, Cebotaru L.   +6 more
europepmc   +1 more source

Immunomodulatory crosstalk between GPCR and hippo signaling in cancer: implications for tumor immunity and therapeutic targeting. [PDF]

Front Immunol
Ren X, Xie T, Liu L, Jin X, Zhang M.
europepmc   +1 more source